311 filings
Page 13 of 16
8-K
jz7cc8f9h tgmg9ce
19 Mar 09
Oragenics, Inc. Announces Management Changes
12:00am
8-K
dqyboc
4 Feb 09
Oragenics, Inc., Announces Agreement
12:00am
8-K
6lp7iu4mluvak9l7yvv
15 Jan 09
Regulation FD Disclosure
12:00am
8-K
akj 8rdz004uc37cj
23 Dec 08
Other Events
12:00am
8-K
xexg122
16 Dec 08
ONI BioPharma Announces EvoraPlus Website Now Available to Consumers
12:00am
8-K
ey70n1tmd1vbdln0oim
10 Dec 08
Oni Biopharma Announces Its Listing
12:00am
8-K
emn15ecdexr lm5n1
5 Dec 08
Proposed Rights Offering to Shareholders
12:00am
8-K
ub4wxhmn
31 Oct 08
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
mv1lo 7phmo3
24 Oct 08
Entry into a Material Definitive Agreement
12:00am
8-K
ls5 m4ss1zmjn
2 Oct 08
Financial Statements and Exhibits
12:00am
8-K
p8q0dd7m pd
2 Jul 08
ONI BioPharma Appoints New Chief Operational Officer
12:00am
8-K
2v593hr3 lalanshze
16 Jun 08
ONI BioPharma Inc. Announces Closing on $2,600,000 in Equity Financing
12:00am
8-K
zsul9nbw21wzvblr1ko
3 Jun 08
ONI BioPharma Inc. Announces Definitive Term Sheet for $2,600,000 in Equity Financing
12:00am
8-K
vv4vbg4ahb3fqk
16 May 08
Oragenics, Inc. (ONI BioPharma Inc.) Receives Notification Letter from American Stock Exchange
12:00am
8-K
mnphrzuwbgz
13 May 08
Other Events
12:00am
8-K
01lrz7
9 May 08
Oragenics Announces Test Marketing of Probiora3™ Chewable Tablets
12:00am
8-K
n4o7jdxp
30 Apr 08
Departure of Directors or Principal Officers
12:00am
8-K
2f5zlz6qq125ftm2ym
14 Apr 08
Departure of Directors or Principal Officers
12:00am
8-K
58ojnh10ht567pdhefx9
4 Mar 08
Oragenics, Inc. Announces the Early Exercise of Warrants
12:00am
8-K
e75fmo1xhtq66
15 Feb 08
Oragenics Announces the Exercise of Warrants and a Management Change
12:00am